- Current report filing (8-K)
August 10 2009 - 4:11PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): August 10, 2009
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
000-33009
(Commission File Number)
|
|
56-2248952
(IRS Employer Identification No.)
|
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 815-7700
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13d-4(c))
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers
Effective August 10, 2009, the Company appointed a new director, James Deal. The compensation
arrangement entered into for the newly appointed director is materially similar to all other
director compensation, as disclosed in the Companys proxy for fiscal year 2008.
On August 10, 2009, the Company issued a press release disclosing these events.
Item 9.01 Financial Statements and Exhibits
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
99.1
|
|
Press Release dated August 10, 2009.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
MEDCATH CORPORATION
|
|
Date: August 10, 2009
|
By:
|
/s/ James A. Parker
|
|
|
|
James A. Parker
|
|
|
|
Interim Chief Financial Officer,
Senior Vice President, Finance and Development
|
|
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024